BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18647599)

  • 1. Application and interpretation of hPXR screening data: Validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducers.
    Cui X; Thomas A; Gerlach V; White RE; Morrison RA; Cheng KC
    Biochem Pharmacol; 2008 Sep; 76(5):680-9. PubMed ID: 18647599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes.
    Luo G; Cunningham M; Kim S; Burn T; Lin J; Sinz M; Hamilton G; Rizzo C; Jolley S; Gilbert D; Downey A; Mudra D; Graham R; Carroll K; Xie J; Madan A; Parkinson A; Christ D; Selling B; LeCluyse E; Gan LS
    Drug Metab Dispos; 2002 Jul; 30(7):795-804. PubMed ID: 12065438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PXR reporter gene assay in a stable cell culture system: CYP3A4 and CYP2B6 induction by pesticides.
    Lemaire G; de Sousa G; Rahmani R
    Biochem Pharmacol; 2004 Dec; 68(12):2347-58. PubMed ID: 15548381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cynomolgus monkey pregnane X receptor, primary hepatocyte, and in vivo pharmacokinetic changes in predicting human CYP3A4 induction.
    Kim S; Dinchuk JE; Anthony MN; Orcutt T; Zoeckler ME; Sauer MB; Mosure KW; Vuppugalla R; Grace JE; Simmermacher J; Dulac HA; Pizzano J; Sinz M
    Drug Metab Dispos; 2010 Jan; 38(1):16-24. PubMed ID: 19833845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers.
    Faucette SR; Wang H; Hamilton GA; Jolley SL; Gilbert D; Lindley C; Yan B; Negishi M; LeCluyse EL
    Drug Metab Dispos; 2004 Mar; 32(3):348-58. PubMed ID: 14977870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
    Raucy J; Warfe L; Yueh MF; Allen SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):412-23. PubMed ID: 12235278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells.
    McGinnity DF; Zhang G; Kenny JR; Hamilton GA; Otmani S; Stams KR; Haney S; Brassil P; Stresser DM; Riley RJ
    Drug Metab Dispos; 2009 Jun; 37(6):1259-68. PubMed ID: 19307295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosulfan induces CYP2B6 and CYP3A4 by activating the pregnane X receptor.
    Casabar RC; Das PC; Dekrey GK; Gardiner CS; Cao Y; Rose RL; Wallace AD
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):335-43. PubMed ID: 20361990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways.
    Cerveny L; Svecova L; Anzenbacherova E; Vrzal R; Staud F; Dvorak Z; Ulrichova J; Anzenbacher P; Pavek P
    Drug Metab Dispos; 2007 Jul; 35(7):1032-41. PubMed ID: 17392393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes.
    Mugundu GM; Hariparsad N; Desai PB
    Drug Metab Lett; 2010 Jan; 4(1):45-50. PubMed ID: 20201776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a stable human cell line, HPL-A3, for use in reporter gene assays of cytochrome P450 3A inducers.
    Sekimoto M; Sano S; Hosaka T; Nemoto K; Degawa M
    Biol Pharm Bull; 2012; 35(5):677-85. PubMed ID: 22687401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application.
    Nibourg GA; Huisman MT; van der Hoeven TV; van Gulik TM; Chamuleau RA; Hoekstra R
    Liver Transpl; 2010 Sep; 16(9):1075-85. PubMed ID: 20818746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor.
    Moscovitz JE; Lin Z; Johnson N; Tu M; Goosen TC; Weng Y; Kalgutkar AS
    Xenobiotica; 2018 Jul; 48(7):647-655. PubMed ID: 28685622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor.
    Faucette SR; Sueyoshi T; Smith CM; Negishi M; Lecluyse EL; Wang H
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1200-9. PubMed ID: 16513849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate.
    Nallani SC; Glauser TA; Hariparsad N; Setchell K; Buckley DJ; Buckley AR; Desai PB
    Epilepsia; 2003 Dec; 44(12):1521-8. PubMed ID: 14636322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.
    Li T; Chiang JY
    Drug Metab Dispos; 2006 May; 34(5):756-64. PubMed ID: 16455805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes.
    Drocourt L; Pascussi JM; Assenat E; Fabre JM; Maurel P; Vilarem MJ
    Drug Metab Dispos; 2001 Oct; 29(10):1325-31. PubMed ID: 11560876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor.
    Yang J; Yan B
    Toxicol Sci; 2007 Jan; 95(1):13-22. PubMed ID: 17003103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction.
    Vignati LA; Bogni A; Grossi P; Monshouwer M
    Toxicology; 2004 Jun; 199(1):23-33. PubMed ID: 15125996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of calibration curve-based approaches to predict clinical inducers and noninducers of CYP3A4 with plated human hepatocytes.
    Zhang JG; Ho T; Callendrello AL; Clark RJ; Santone EA; Kinsman S; Xiao D; Fox LG; Einolf HJ; Stresser DM
    Drug Metab Dispos; 2014 Sep; 42(9):1379-91. PubMed ID: 24924386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.